Online-only Table 1 Studies selected for meta-analysis.
From: Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
Dataset | Reference | Brain region | MS approach | Lysis buffer | Sample size | Age (mean) | PMI (h) (mean) | Gender (Female/Male) | APOE4 status | Braak stage | Number of proteins* |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Haytural et al. Mol Cell Proteomics, 202014 | Outer 2/3 of the molecular layer (Dentate gyrus)# | TMT | SDS-based | 5 AD | 91 ± 4.3 | 5.17 ± 1.3 | 4 F / 1 M | 2/5 | IV | 7458 |
5 C | 81.8 ± 9.2 | 6.8 ± 1 | 4 F / 1 M | 1/5 | 0-II | ||||||
2 | Schedin-Weiss et al. (manuscript in preparation) | Frontal cortex‡ | 18O | Urea-based | 5 AD | 81 ± 5 | 6.3 ± 1.1 | 3 F / 2 M | n/a | III – VI | 2298 |
5 C | 79 ± 6 | 6.8 ± 2 | 3 F / 2 M | 0-II | |||||||
3 | Hippocampus# | 5 AD | 81 ± 5 | 6.3 ± 1.1 | 3 F / 2 M | n/a | III – VI | 2251 | |||
5 C | 79 ± 6 | 6.8 ± 2 | 3 F / 2 M | 0-II | |||||||
4 | Bereczki et al. Brain, 20188 | Dorsolateral prefrontal cortex (BA9)‡ | TMT | SDS-based | 9 AD | 85.6 ± 6.5 | 23.7 ± 10 | 6 F / 3 M | n/a | - | 7097 |
8 C | 83 ± 3.8 | 35.2 ± 18.4 | 4 F / 4 M | ||||||||
5 | Mendonça et al. Neurobiol Dis, 201919 | Entorhinal cortex# | Label-free | Urea-based | 6 AD | 82.8 ± 5.19 | 4.58 ± 1.5 | 4 F / 2 M | n/a | IV – VI | 2014 |
7 C | 65 ± 10.2 | 4.36 ± 2.43 | 1 F / 6 M | n/a | |||||||
6 | Frontal cortex‡ | 10 AD | 82.5 ± 6.06 | 5.25 ± 0.89 | 8 F / 2 M | n/a | IV – VI | 2230 | |||
7 C | 58.3 ± 12.7 | 5.29 ± 3.4 | 2 F / 5 M | n/a | |||||||
7 | Parahippocampal cortex# | 5 AD | 80.2 ± 9.42 | 4.9 ± 0.74 | 5 F | n/a | V – IV | 2204 | |||
11 C | 64.1 ± 14.1 | 4.77 ± 2.79 | 4 F / 7 M | n/a | |||||||
8 | Temporal cortex# | 11 AD | 81.2 ± 8.05 | 5 ± 1.28 | 9 F / 2 M | n/a | IV – VI | 2101 | |||
7 C | 58.3 ± 12.7 | 5.29 ± 3.4 | 2 F / 5 M | n/a | |||||||
9 | Ping et al. Sci Data, 201812 | BA9‡ | TMT | Urea-based | 10 AD | 65.1 ± 7.43 | 5.4 ± 1.5 | 5 F / 5 M | 7/10 | V – VI | 7129 |
10 C | 63.7 ± 10.2 | 9.3 ± 7.09 | 5 F / 5 M | 2/10 | 0 - II | ||||||
10 | Johnson et al. Mol Neurodegener, 201810 | BA9‡ | TMT | Urea-based | 20 AD | 86.3 ± 8.7 | 14.2 ± 4.9 | 10 F / 10 M | 7/20 | IV – VI | 5888 |
13 C | 81.3 ± 10.9 | 17.4 ± 5.8 | 3 F / 10 M | 1/13 | I-III | ||||||
11 | Johnson et al. Nat Med, 20206 | BA9‡ | Label-free | Urea-based | 252 AD | - | 5.8 ± 4.6 | 141 F / 111 M | n/a | III – VI | 2793 |
94 C | - | 8.2 ± 6.6 | 44 F / 50 M | 0 - III | |||||||
12 | Temporal cortex# | 83 AD | 82.3 ± 7.7 | 7.6 ± 4.8 | 47 F / 36 M | 43/83 | IV – VI | 3286 | |||
28 C | 89 ± 1.4 | 11.3 ± 8.7 | 17 F / 11 M | 3/28 | 0 - III | ||||||
13 | BA9‡ | 49 AD | 78.1 ± 10.7 | 12.7 ± 5.4 | 27 F / 22 M | n/a | ? | 2249 | |||
46 C | 65.2 ± 8.9 | 14.7 ± 4. 9 | 19 F / 27 M | ? | |||||||
14 | Bai et al. Neuron, 20209 | Frontal gyrus‡ | TMT | Urea-based | 15 AD | 78 ± 8.5 | 3.1 ± 0.92 | 9 F / 6 M | n/a | V – VI | 12521 |
18 C | 84.9 ± 5.9 | 2.6 ± 0.7 | 8 F / 10 M | I - IV | |||||||
15 | Frontal gyrus‡ | 39 AD | 84 ± 10.1 | 6.4 ± 4.4 | 27 F / 12 M | 22/39 | II – VI | 12147 | |||
23 C | 80.8 ± 10.4 | 9.5 ± 6.3 | 11 F / 12 M | 2/23 | 0 - III | ||||||
16 | Zhang et al. Acta Neuropathol Commun., 20187 | Frontal cortex‡ | Label-free | SDS-based | 8 AD | 70.8 ± 5.84 | 7.2 ± 4.06 | 2 F / 6 M | 4/8 | V – VI | 1968 |
8 C | 70.8 ± 11.8 | 7.5 ± 2.6 | 4 F / 4 M | 1/8 | 0 - II | ||||||
17 | Xu et al. Commun Biol., 201911 | Hippocampus# | iTRAQ | SDS-based | 6 AD | 70.6 ± 7.8 | 6.5 ± 1.3 | 3 F / 3 M | n/a | V – VI | 2910 |
6 C | 69.1 ± 7.3 | 10.2 ± 3.1 | 3 F / 3 M | n/a | |||||||
18 | Entorhinal cortex# | 9 AD | 70.3 ± 7 | 6.8 ± 2.3 | 4 F / 5 M | n/a | IV – VI | 2585 | |||
9 C | 70.1 ± 6.6 | 9.6 ± 2.6 | 4 F / 5 M | n/a | |||||||
Concatenated data (input for meta-analysis) | Sample size | Number of proteins | |||||||||
Labeled data | 123 AD | 17296 | |||||||||
102 C | |||||||||||
Label-free data | 424 AD | 4292 | |||||||||
208 C | |||||||||||